Compare TMDX & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | ONDS |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.8B |
| IPO Year | 2019 | N/A |
| Metric | TMDX | ONDS |
|---|---|---|
| Price | $141.71 | $12.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $144.25 | $12.60 |
| AVG Volume (30 Days) | 660.2K | ★ 97.0M |
| Earning Date | 02-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.70 | N/A |
| EPS | ★ 2.54 | N/A |
| Revenue | ★ $566,354,000.00 | $24,748,922.00 |
| Revenue This Year | $38.81 | $417.68 |
| Revenue Next Year | $20.49 | $244.11 |
| P/E Ratio | $56.53 | ★ N/A |
| Revenue Growth | 41.20 | ★ 208.40 |
| 52 Week Low | $55.00 | $0.57 |
| 52 Week High | $156.00 | $15.28 |
| Indicator | TMDX | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 63.09 | 57.94 |
| Support Level | $134.00 | $12.83 |
| Resistance Level | $151.85 | $15.28 |
| Average True Range (ATR) | 6.57 | 1.34 |
| MACD | 1.73 | 0.09 |
| Stochastic Oscillator | 68.91 | 57.50 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.